-
公开(公告)号:US5340809A
公开(公告)日:1994-08-23
申请号:US929993
申请日:1992-08-13
申请人: Michel Gaudry , Bruno Pfeiffer , Pierre Renard , Jean-Francois Renaud de la Faverie , Gerard Adam
发明人: Michel Gaudry , Bruno Pfeiffer , Pierre Renard , Jean-Francois Renaud de la Faverie , Gerard Adam
IPC分类号: A61K31/495 , A61P9/00 , A61P9/08 , A61P9/10 , A61P25/28 , A61P27/16 , C07D207/09 , C07D207/16 , C07D209/16 , C07D209/20 , C07D209/42 , C07D233/64 , C07D295/18 , C07D295/185 , C07D295/205 , C07D453/06 , C07D403/06
CPC分类号: C07D295/185 , C07D207/09 , C07D209/16 , C07D295/205
摘要: A compound selected from those of formula (I): ##STR1## with R.sub.1, R.sub.2 and n as defined in the description, and medicinal products containing the same useful in treating or in preventing a disorder resulting from cellular damages following upon ischemia, hypoxia, or anoxia.
摘要翻译: 选自式(I)的化合物:如描述中所定义的具有R1,R2和n的式(I)化合物和含有该化合物的药物可用于治疗或预防由局部缺血后细胞损伤引起的疾病 ,缺氧或缺氧。